The RAS-24: Development and validation of an adherence-to-medication scale for severe mental illness patients

Sandra I. Ralat, José Rodríguez-Gómez

Open source

DOI
10.1017/cts.2023.527
Published
2023
Container
Journal of Clinical and Translational Science
Publisher
Cambridge University Press (CUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1017/cts.2023.527,
  title = {The RAS-24: Development and validation of an adherence-to-medication scale for severe mental illness patients},
  author = {Sandra I. Ralat and José Rodríguez-Gómez},
  year = {2023},
  journal = {Journal of Clinical and Translational Science},
  doi = {10.1017/cts.2023.527},
  url = {https://doi.org/10.1017/cts.2023.527}
}

RIS

TY  - JOUR
TI  - The RAS-24: Development and validation of an adherence-to-medication scale for severe mental illness patients
AU  - Sandra I. Ralat
AU  - José Rodríguez-Gómez
PY  - 2023
JO  - Journal of Clinical and Translational Science
DO  - 10.1017/cts.2023.527
UR  - https://doi.org/10.1017/cts.2023.527
ER  - 

APA

Ralat, S. I., & Rodríguez-Gómez, J. (2023). The RAS-24: Development and validation of an adherence-to-medication scale for severe mental illness patients. Journal of Clinical and Translational Science. https://doi.org/10.1017/cts.2023.527

Source records